Cargando…
Failing upwards: Genetics-based strategies to improve antibiotic discovery and efficacy in Mycobacterium tuberculosis
Therapeutic advances in the 20th century significantly reduced tuberculosis (TB) mortality. Nonetheless, TB still poses a massive global health challenge with significant annual morbidity and mortality that has been amplified during the COVID-19 pandemic. Unlike most common bacterial infectious dise...
Autores principales: | Tomasi, Francesca G., Rubin, Eric J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519881/ https://www.ncbi.nlm.nih.gov/pubmed/36189351 http://dx.doi.org/10.3389/fcimb.2022.932556 |
Ejemplares similares
-
Bioenergetic Inhibitors: Antibiotic Efficacy and Mechanisms of Action in Mycobacterium tuberculosis
por: Hasenoehrl, Erik J., et al.
Publicado: (2021) -
Tools to develop antibiotic combinations that target drug tolerance in Mycobacterium tuberculosis
por: Greenstein, Talia, et al.
Publicado: (2023) -
How Mycobacterium tuberculosis drug resistance has shaped anti-tubercular drug discovery
por: Bhagwat, Amala, et al.
Publicado: (2022) -
Enhancement of CD4(+) T Cell Function as a Strategy for Improving Antibiotic Therapy Efficacy in Tuberculosis: Does It Work?
por: Costa, Diego L., et al.
Publicado: (2021) -
Genetic Diversity of Mycobacterium tuberculosis Isolates From an Amerindian Population in Chiapas, México
por: Molina-Torres, Carmen A., et al.
Publicado: (2022)